Should You Buy Pacific Biosciences of California (PACB)?

Page 2 of 2

Using the results explained by the previously mentioned strategies, average investors should always track hedge fund and insider trading activity, and Pacific Biosciences of California (NASDAQ:PACB) is no exception.

Discover how hedge fund piggybacking can benefit you

Recommended Reading:

Dell, Nuance Among Carl Icahn’s Dividend Favorites

This Week On The U.S. Economic Radar

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 7 0 0
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) 8 0 0
Geron Corporation (NASDAQ:GERN) 7 0 0
ImmunoCellular Therapeutics Ltd (NYSEAMEX:IMUC) 0 0
Targacept , Inc. (NASDAQ:TRGT) 8 0 0
Page 2 of 2